![]() |
![]() |
![]() |
|
Vol. 8, Nos. 1-50, pp. 1-1650 Jan. 1 -- Dec. 31, 2010 # | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Cacchillo v. Insmed Inc. (N.D.N.Y.), 1399
Cadila Healthcare Ltd.; Shire Dev. Inc. v. (D. Del.), 947 Cain v. Merck & Co. (N.J. Super. Ct. App. Div.), 1147 Caldwell ex rel. Louisiana v. Janssen Pharmaceutica Inc. (La. Parish Ct.), 1342 California Pharmacists Ass'n v. Maxwell-Jolly (9th Cir.), 319 Campbell v. Matrixx Initiatives Inc. (D. Idaho), 239 Cancer Research Tech. Ltd. v. Barr Labs. Inc. (D. Del.), 385; (Fed. Cir.), 385; 1457 Cancer Research Tech. Ltd. v. Teva Pharms. USA Inc. (D. Del.), 119 Caraco Pharm. Labs. Ltd.; Novo Nordisk A/S v. (Fed. Cir.), 512; 1016; (E.D. Mich.), 1303 CareToLive v. FDA (6th Cir.), 203 Carpenter, U.S. ex rel. v. Abbott Labs. (D. Mass.), 943 Celgene Corp.; Attorney Gen. of Canada v. (Canada, Fed. Ct. App.), 533; (Canada), 570 Celgene Corp. v. Teva Pharms. USA Inc. (D.N.J.), 156 Centocor Inc. v. Abbott Labs. (E.D. Tex.), 6 Centocor Inc. v. Hamilton (Tex. Ct. App.), 317 Centocor Ortho Biotech Inc.; DeGidio v. (N.D. Ohio), 1469 Cephalon Inc. v. Apotex Corp. (D. Del.), 1107 Cephalon Inc.; Giant Eagle Inc. v. (N.D. Ohio), 748 Cephalon Inc.; King Drug Co. of Florence Inc. v. (E.D. Pa.), 412 Cephalon Inc. v. Watson Pharms. Inc. (D. Del.), 36 Chanin v. Teva Parenteral Medicines Inc. (Nev. Dist. Ct.), 625 Chartock, U.S. ex rel. v. Elan Corp. (D. Mass.), 1578 Cipro Cases I and II, In re (Cal. Ct. App.), 681 Ciprofloxacin Hydrochloride Antitrust Litig., In re (2d Cir.), 579 City of Classen Immunotherapies v. Biogen Idec Inc. (U.S., rem), 851 Clayworth v. Pfizer Inc. (Cal.), 914; (Cal. Ct. App.), 1183 Coalition for Common Sense in Gov't Procurement v. U.S. (D.D.C.), 210 Cobalt Pharms. Inc.; Hoffmann-LaRoche Inc. v. (D.N.J.), 1087; 1182; 1460 Cochran v. Wyeth Inc. (Pa. Super. Ct.), 1022 Cody Labs. Inc. v. Sebelius (D. Wyo.), 980; 1500 Colacicco v. Apotex Inc. (E.D. Pa.), 11 Coleman v. Wyeth Pharms. Inc. (Pa. Super. Ct.), 1220 Conrad, U.S. ex rel. v. Eon Labs Inc. (D. Mass.), 232 Conrad, U.S. ex rel. v. Grifols Biologicals Inc. (D. Md.), 918; 1143 Conrad, U.S. ex rel. v. Schwarz Pharma (D. Mass.), 585 Conrad, U.S. ex rel. v. Schwarz Pharma (S.D. Tex.), 585 Cooper v. Matrixx Initiatives Inc. (D. Idaho), 239 Cooper v. Wyeth Inc. (M.D. La.), 1401 Copeland, U.S. ex rel. v. Novartis Pharms. Corp. (E.D. Pa.), 1269 CorePharma LLC; King Pharms. Inc. v. (D.N.J.), 641 County of CVS Caremark Corp.; Muecke Co. v. (S.D. Tex.), 1307 CVS Pharmacy Inc., In re (Mass. Super. Ct.), 1156 Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |